… to validate it in a large cohort of patients with MDS or transformed AML from the EBMT
database. Although the IPSS-R was originally developed for untreated MDS … with MDS and MDS …

… -center retrospective validation cohort study including adults with a known diagnosis of MDS
… Patients were identified using relevant diagnostic codes for MDS and those who were <18 …

… The primary limitation of our study is its retrospective nature. In particular, the number of visits
… Also, we did not validate DT findings against other measures, such as the Hospital Anxiety …

… -center retrospective validation cohort study of adults with a known diagnosis of MDS referred
… Patients were identified using relevant diagnostic codes for MDS and those who were <18 …

… Myelodysplastic syndromes (MDS) are heterogeneous neoplasms ranging from indolent …
Our study may present some limitations, mainly because of the retrospective nature of the …

… This study aimed to validate the findings of the original in a large cohort of MDS patients,
as well as assess its validity in therapy-related and hypoplastic MDS. We retrospectively …

… events including cases of myelodysplastic syndrome and acute … the risk of myelodysplastic
syndrome and acute myeloid … inhibitor-related myelodysplastic syndrome and acute myeloid …

… in MDS have become increasingly common, but with limited data on efficacy. We therefore
performed a retrospective … in our cohort has not been validated in this setting and cannot give …

… curative option for myelodysplastic syndromes (MDSs) but is … Myelodysplastic syndromes
(MDSs) mostly affect elderly … ] has been validated in both prospective and retrospective studies …

… This is a retrospective … Validation of the proposed model in an independent cohort is
underway. Although the new model can be used for patients with secondary MDS, validation in this …